1. Home
  2. BLDP vs ALVO Comparison

BLDP vs ALVO Comparison

Compare BLDP & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ballard Power Systems Inc.

BLDP

Ballard Power Systems Inc.

HOLD

Current Price

$3.51

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.60

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDP
ALVO
Founded
1979
2013
Country
Canada
Luxembourg
Employees
N/A
1460
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
BLDP
ALVO
Price
$3.51
$3.60
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$2.34
$8.00
AVG Volume (30 Days)
7.5M
1.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.53
$13.28
Revenue Next Year
$18.02
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$1.65
$2.94
52 Week High
$6.57
$9.94

Technical Indicators

Market Signals
Indicator
BLDP
ALVO
Relative Strength Index (RSI) 35.02 46.87
Support Level $2.55 $3.55
Resistance Level $3.71 $3.83
Average True Range (ATR) 0.36 0.23
MACD -0.09 -0.05
Stochastic Oscillator 1.33 14.00

Price Performance

Historical Comparison
BLDP
ALVO

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from United States followed by Poland, Canada, and other countries.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: